Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 May;91(1):77–87. doi: 10.1111/j.1476-5381.1987.tb08985.x

Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.

G J Sanger
PMCID: PMC1853491  PMID: 3594084

Abstract

The mechanisms by which BRL 24924 ([(+/-)- (endo)])-4-amino-5-chloro-2-methoxy-N-(1-azabicyclo-[3.3.1]-non- 4-yl) benzamide hydrochloride stimulates gut motility and the relationships between BRL 24924 and 5-hydroxytryptamine (5-HT) receptors have been studied. In guinea-pig isolated ileum, BRL 24924 (10(-14)-10(-6) M) increased electrically-evoked, cholinergically-mediated contractions, probably by increasing acetylcholine (ACh) release. This action of BRL 24924 was prevented by the presence of high concentrations of 5-HT, but not by hexamethonium, phentolamine and propranolol, methysergide or ICS 205-930. The mechanism by which BRL 24924 can increase gut ACh release is not certain, but most likely involves activation of an enteric 5-HT receptor which differs from those 5-HT M-receptors antagonized by ICS 205-930 or by higher concentrations of BRL 24924 in other test systems. BRL 24924 antagonized 5-HT-evoked, cholinergically-mediated contractions of guinea-pig isolated ileum (pA2 = 7.56 +/- 0.12). Similar and higher concentrations of BRL 24924 did not antagonize contractions evoked by nicotinic receptor stimulation. In rabbit isolated heart, BRL 24924 1-10 nM reduced the tachycardia evoked by 5-HT. In anaesthetized rats, BRL 24924 0.3-83 nmol kg-1 i.v. antagonized the Bezold-Jarisch reflex evoked by 5-HT; the ID50 for BRL 24924 was 10.2 +/- 3.0 nmol kg-1 (3.7 +/- 1.1 microgram kg-1). A direct action of BRL 24924 on nerve function was excluded. In rat cortex, BRL 24924 10(-6) M did not displace [3H]-5-HT or [3H]-ketanserin binding to 5-HT1 and 5-HT2 receptors. The actions of BRL 24924 are discussed in terms of its potential clinical use as a stimulant of gastric motility and as a 5-HT M-receptor antagonist.

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ambache N., Freeman M. A. Atropine-resistant longitudinal muscle spasms due to excitation of non-cholinergic neurones in Auerbach's plexus. J Physiol. 1968 Dec;199(3):705–727. doi: 10.1113/jphysiol.1968.sp008674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett J. P., Jr, Snyder S. H. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol. 1976 May;12(3):373–389. [PubMed] [Google Scholar]
  4. Bianchi C., Beani L., Crema C. Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs. Eur J Pharmacol. 1970;12(3):332–341. doi: 10.1016/0014-2999(70)90085-3. [DOI] [PubMed] [Google Scholar]
  5. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986 Jun;25(6):563–576. doi: 10.1016/0028-3908(86)90207-8. [DOI] [PubMed] [Google Scholar]
  6. Buchheit K. H., Costall B., Engel G., Gunning S. J., Naylor R. J., Richardson B. P. 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo. J Pharm Pharmacol. 1985 Sep;37(9):664–667. doi: 10.1111/j.2042-7158.1985.tb05109.x. [DOI] [PubMed] [Google Scholar]
  7. Buchheit K. H., Engel G., Mutschler E., Richardson B. Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 1985 Mar;329(1):36–41. doi: 10.1007/BF00695189. [DOI] [PubMed] [Google Scholar]
  8. Chahl L. A. Substance P mediates atropine-sensitive response of guinea-pig ileum to serotonin. Eur J Pharmacol. 1983 Mar 4;87(4):485–489. doi: 10.1016/0014-2999(83)90090-0. [DOI] [PubMed] [Google Scholar]
  9. Clineschmidt B. V., Reiss D. R., Pettibone D. J., Robinson J. L. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J Pharmacol Exp Ther. 1985 Dec;235(3):696–708. [PubMed] [Google Scholar]
  10. Costa M., Furness J. B. The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon. Br J Pharmacol. 1979 Feb;65(2):237–248. doi: 10.1111/j.1476-5381.1979.tb07824.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Costall B., Naylor R. J., Tan C. C. Neuronally mediated contraction responses of guinea-pig stomach smooth muscle preparations: modification by benzamide derivatives does not reflect a dopamine antagonist action. Eur J Pharmacol. 1984 Jun 15;102(1):79–89. doi: 10.1016/0014-2999(84)90340-6. [DOI] [PubMed] [Google Scholar]
  12. Fozard J. R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):36–44. doi: 10.1007/BF00518776. [DOI] [PubMed] [Google Scholar]
  13. Fozard J. R. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 1984 Dec;23(12B):1473–1486. doi: 10.1016/0028-3908(84)90091-1. [DOI] [PubMed] [Google Scholar]
  14. GADDUM J. H., PICARELLI Z. P. Two kinds of tryptamine receptor. Br J Pharmacol Chemother. 1957 Sep;12(3):323–328. doi: 10.1111/j.1476-5381.1957.tb00142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Görich R., Weihrauch T. R., Kilbinger H. The inhibition by dopamine of cholinergic transmission in the isolated guinea-pig ileum. Mediation through alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):308–312. doi: 10.1007/BF00501170. [DOI] [PubMed] [Google Scholar]
  16. Harrington R. A., Hamilton C. W., Brogden R. N., Linkewich J. A., Romankiewicz J. A., Heel R. C. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs. 1983 May;25(5):451–494. doi: 10.2165/00003495-198325050-00002. [DOI] [PubMed] [Google Scholar]
  17. Kilbinger H., Kruel R., Pfeuffer-Friederich I., Wessler I. The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):231–238. doi: 10.1007/BF00495871. [DOI] [PubMed] [Google Scholar]
  18. Kilbinger H., Pfeuffer-Friederich I. Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus. Br J Pharmacol. 1985 Jun;85(2):529–539. doi: 10.1111/j.1476-5381.1985.tb08890.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leysen J. E., Niemegeers C. J., Van Nueten J. M., Laduron P. M. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol. 1982 Mar;21(2):301–314. [PubMed] [Google Scholar]
  20. Loisy C., Beorchia S., Centonze V., Fozard J. R., Schechter P. J., Tell G. P. Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study. Cephalalgia. 1985 Jun;5(2):79–82. doi: 10.1046/j.1468-2982.1985.0502079.x. [DOI] [PubMed] [Google Scholar]
  21. Miner W. D., Sanger G. J. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol. 1986 Jul;88(3):497–499. doi: 10.1111/j.1476-5381.1986.tb10228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Parantainen J., Hakkarainen H., Vapaatalo H., Gothoni G. Prostaglandin inhibitors and gastric factors in migraine. Lancet. 1980 Apr 12;1(8172):832–833. doi: 10.1016/s0140-6736(80)91344-6. [DOI] [PubMed] [Google Scholar]
  23. Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985 Jul 11;316(6024):126–131. doi: 10.1038/316126a0. [DOI] [PubMed] [Google Scholar]
  24. Round A., Wallis D. I. Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists. Neuropharmacology. 1987 Jan;26(1):39–48. doi: 10.1016/0028-3908(87)90042-6. [DOI] [PubMed] [Google Scholar]
  25. Sanger G. J. Effects of metoclopramide and domperidone on cholinergically mediated contractions of human isolated stomach muscle. J Pharm Pharmacol. 1985 Sep;37(9):661–664. doi: 10.1111/j.2042-7158.1985.tb05108.x. [DOI] [PubMed] [Google Scholar]
  26. Sanger G. J., McClelland C. M. Increased gastric cholinergic activity evoked by 5-hydroxy-L-tryptophan in the rat. Eur J Pharmacol. 1986 Aug 15;127(3):179–185. doi: 10.1016/0014-2999(86)90362-6. [DOI] [PubMed] [Google Scholar]
  27. Sanger G. J. The effects of various pharmacological agents on the metoclopramide-induced increase in cholinergic-mediated contractions of rat isolated forestomach. Eur J Pharmacol. 1985 Aug 15;114(2):139–145. doi: 10.1016/0014-2999(85)90621-1. [DOI] [PubMed] [Google Scholar]
  28. Sanger G. J. Three different ways in which 5-hydroxytryptamine can affect cholinergic activity in guinea-pig isolated ileum. J Pharm Pharmacol. 1985 Aug;37(8):584–586. doi: 10.1111/j.2042-7158.1985.tb03076.x. [DOI] [PubMed] [Google Scholar]
  29. Schuurkes J. A., Van Nueten J. M., Van Daele P. G., Reyntjens A. J., Janssen P. A. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther. 1985 Sep;234(3):775–783. [PubMed] [Google Scholar]
  30. VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]
  31. Wallis D. Neuronal 5-hydroxytryptamine receptors outside the central nervous system. Life Sci. 1981 Dec 7;29(23):2345–2355. doi: 10.1016/0024-3205(81)90470-7. [DOI] [PubMed] [Google Scholar]
  32. Wikberg J. Differentiation between pre- and postjunctional alpha-receptors in guinea pig ileum and rabbit aorta. Acta Physiol Scand. 1978 Jul;103(3):225–239. doi: 10.1111/j.1748-1716.1978.tb06210.x. [DOI] [PubMed] [Google Scholar]
  33. Williams F. M., Rothaul A. L., Kane K. A., Parratt J. R. Antiarrhythmic and electrophysiological effects of ICS 205-930, an antagonist of 5-hydroxytryptamine at peripheral receptors. J Cardiovasc Pharmacol. 1985 May-Jun;7(3):550–555. doi: 10.1097/00005344-198505000-00022. [DOI] [PubMed] [Google Scholar]
  34. Zar M. A., Ebong O., Bateman D. N. Effect of metoclopramide in guinea-pig ileum longitudinal muscle: evidence against dopamine-mediation. Gut. 1982 Jan;23(1):66–70. doi: 10.1136/gut.23.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES